PharmaShots | Incisive News in 3 Shots

Subscribe Now

Abata Therapeutics

Abata Therapeutics' ABA-101 Gets the US FDA FTD to Treat Progressive Multiple Sclerosis (MS)

Abata Therapeutics' ABA-101 Gets the US FDA FTD to Treat Progressive Multiple Sclerosis (MS)

August 23, 2024

Abata Therapeutics Receives Investment from BMS for the Advancement of Treg Cell Therapies

Abata Therapeutics Receives Investment from BMS for the Advancement of Treg Cell Therapies

August 16, 2024

Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis

Abata Therapeutics Reports the US FDA’s IND Clearance for P-I Trial of ABA-101 for Progressive Multiple Sclerosis

July 9, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us